The antifungal properties of chicken egg cystatin against Candida yeast isolates showing different levels of azole resistance

Mycoses

Volumn 53, Issue 4, 2010, Pages 314-320

  Kolaczkowska, Anna ^a   Kolaczkowski, Marcin ^b   Sokolowska, Agata ^c   Miecznikowska, Hanna ^d   Kubiak, Agnieszka ^c   Rolka, Krzysztof ^d   Polanowski, Antoni ^c  

^a WROCLAW UNIVERSITY OF ENVIRONMENTAL AND LIFE SCIENCES   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

^c UNIVERSITY OF WROC AW   (Poland)

^d UNIVERSITY OF GDA SK   (Poland)

Author keywords

Antimicrobial peptide; Cystatin; Fluconazole; Histatin; Multidrug resistance; Proteinase inhibitor; Yeast

Indexed keywords

AMPHOTERICIN B; CHICKEN EGG WHITE CYSTATIN; CYSTATIN; FLUCONAZOLE; GLYCOPROTEIN P; GLYCOPROTEIN P CDR1P; GLYCOPROTEIN P CDR2P; HISTATIN 5; UNCLASSIFIED DRUG; ANTIFUNGAL AGENT; CARRIER PROTEIN; FUNGAL PROTEIN; HISTATIN; HTN3 PROTEIN, HUMAN; PYRROLE DERIVATIVE;

ANTIFUNGAL ACTIVITY; ANTIFUNGAL RESISTANCE; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CONTROLLED STUDY; DRUG ANTAGONISM; FUNGICIDAL ACTIVITY; GROWTH INHIBITION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; AFFINITY CHROMATOGRAPHY; ANIMAL; BIOSYNTHESIS; CHEMISTRY; CHICKEN; DRUG EFFECTS; GENE EXPRESSION; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; OOCYTE;

CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS;

AMPHOTERICIN B; ANIMALS; ANTIFUNGAL AGENTS; AZOLES; CANDIDA; CHICKENS; CHROMATOGRAPHY, AFFINITY; CYSTATINS; DRUG RESISTANCE, FUNGAL; FLUCONAZOLE; FUNGAL PROTEINS; GENE EXPRESSION; HISTATINS; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; OVUM;

EID: 77953332555     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2009.01722.x     Document Type: Article

References (42)

1. Fidel PL Jr., Vazquez JA, Sobel JD. Candida glabrata review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin Microbiol Rev 1999 12 : 80 96.
2. Richer SS, Galask RP, Messer SA, Hollis RJ, Diekema DJ, Pfaller MA. Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases. J Clin Microbiol 2005 43 : 2155 2162.
3. Sanglard D, Ischer F, Monod M, Bille J. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene. Microbiology 1997 143 : 405 416.
4. White TC. The presence of an R467K amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14-alpha demethylase in Candida albicans. Antimicrob Agents Chemother 1997 41 : 1488 1494.
5. Prasad R, Gaur NA, Gaur M, Komath SS. Efflux pumps in drug resistance of Candida. Infect Disord Drug Targets 2006 6 : 69 83.
6. Odds F. Epidemiological shifts in opportunistic and nosocomial Candida infections: mycological aspects. Int J Antimicrob Agents 1996 6 : 141 144.
7. Turk B, Turk D, Salvesen GS. Regulating cysteine protease activity: essential role of protease inhibitors as guardians and regulators. Curr Pharm Des 2002 8 : 1623 1637.
8. Henskens YM, Veerman EC, Nieuw Amerongen AV. Cystatins in health and disease. Biol Chem Hoppe-Seyler 1996 377 : 71 86.
9. Collins AR, Grubb A. Cystatin D, a natural salivary cysteine protease inhibitor, inhibits coronavirus replication at its physiologic concentration. Oral Microbiol Immunol 1998 13 : 59 61.
10. Björck L, Grubb A, Kjellén L. Cystatin C, a human proteinase inhibitor, blocks replication of herpes simplex virus. J Virol 1990 64 : 941 943.
11. Cimerman N, Kosorok MD, Korant BD, Turk B, Turk V. Characterization of cystatin C from bovine parotid glands: cysteine proteinase inhibition and antiviral properties. Biol Chem Hoppe Seyler 1996 377 : 19 23.
12. Agarwala KL, Kawabata S, Hirata M, Miyagi M, Tsunasawa S, Iwanaga S. A cysteine protease inhibitor stored in the large granules of horseshoe crab hemocytes: purification, characterization, cDNA cloning and tissue localization. J Biochem 1996 119 : 85 94.
13. Blankenvoorde MF, Henskens YM, van't Hof W, Veerman EC, Amerongen N. Inhibition of the growth and cysteine proteinase activity of Porphyromonas gingivalis by human salivary cystatin S and chicken cystatin. Biol Chem 1996 377 : 847 850.
14. Naito Y, Sasaki M, Umemoto T et al. Bactericidal effect of rat cystatin S on an oral bacterium Porphyromonas gingivalis. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 1995 110 : 71 75.
15. Turk V, Bode W. The cystatins: protein inhibitors of cysteine proteinases. FEBS Lett 1991 285 : 213 219.
16. Korant BD, Brzin J, Turk V. Cystatin, a protein inhibitor of cystein proteinases alters viral protein cleavages in infected human cells. Biochem Biophys Res Commun 1985 127 : 1072 1076.
17. Jasir A, Kasprzykowski F, Kasprzykowska R, Lindström V, Schalén C, Grubb A. New antimicrobial cystatin C-based peptide active against Gram-positive bacterial pathogens, including methicillin-resistant Staphylococcus aureus and multiresistant coagulase-negative staphylococci. APMIS 2003 111 : 1004 1010.
18. Wȩsierska E, Saleh Y, Trziszka T, Kopec W, Siewinski M, Korzekwa K. Antimicrobial activity of chicken egg white cystatin. Word J Microb Biotech 2005 21 : 59 64.
19. Martínez M, López-Solanilla E, Rodríguez-Palenzuela P, Carbonero P, Díaz I. Inhibition of plant-pathogenic fungi by the barley cystatin Hv-CPI (gene Icy) is not associated with its cysteine-proteinase inhibitory properties. Mol Plant Microbe Interact 2003 16 : 876 883.
20. Martinez M, Abraham Z, Gambardella M, Echaide M, Carbonero P, Diaz I. Strawberry gene Cyf1 encodes a phytocystatin with antifungal properties. Exp Bot 2005 56 : 1821 1829.
21. Helmerhorst EJ, van't Hof W, Veerman EC, Simoons-Smit I, Nieuw Amerongen AV. Synthetic histatin analogues with broad-spectrum antimicrobial activity. Biochem J 1997 326 : 39 45.
22. Oppenheim FG, Xu T, McMillian FM et al. Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure, and fungistatic effects on Candida albicans. J Biol Chem 1988 263 : 7472 7477.
23. Sanguinetti M, Posteraro B, Fiori B, Ranno S, Torelli R, Fadda G. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a Hospital Survey of antifungal resistance. Antimicrob Agents Chemother 2005 49 : 668 679.
24. White TC, Holleman S, Dy F, Mirels LF, Stevens DA. Resistance mechanisms in clinical isolates of Candida albicans. Antimicrob Agents Chemother 2002 46 : 1704 1713.
25. Kolaczkowski M, Kolaczkowska A, Motohashi N, Michalak K. A new high-throughput screening assay to reveal similarities and differences in inhibitory sensitivity of multidrug ATP-binding cassette transporters. Antimicrob Agents Chemother 2009 53 : 1516 1527.
26. Łȩgowska A, Bulak E, Wysocka M et al. Peptomeric analogues of trypsin inhibitor SFTI-1 isolated from sunflower seeds. Bioorg Med Chem 2008 16 : 5644 5652.
27. Sokołowska A, Kubiak A, Trziszka T, Polanowski A. Rapid one step separation of proteinaceous agent of antimicrobial activity from hen's egg white. Pol J Food Nutr Sci 2007 57 : 499 502.
28. Anastasi A, Brown MA, Kembhavi AA et al. Cystatin, a protein inhibitor of cysteine proteinases. Biochem J 1983 211 : 129 138.
29. Gaddour K, Vincente-Carbajosa J, Lara P, Isabel-LaMoneda I, Diaz I, Carbonero P. A constitutive cystatin-encoding gene from barley (Icy) responds differentially to abiotic stimuli. Plant Mol Biol 2001 45 : 599 608.
30. Smith PK, Krohn RI, Hermanson GT et al. Measurement of protein using bicinchoninic acid. Anal Biochem 1985 150 : 76 85.
31. Helmerhorst EJ, Venuleo C, Beri A, Oppenheim FG. Candida glabrata is unusual with respect to its resistance to cationic antifungal proteins. Yeast 2005 22 : 705 714.
32. Eliopoulos GM, Moellering RC. Antimicrobial combinations. In : Lorian V (ed Antibiotics in Laboratory Medicine, 3rd edn. Baltimore, MD: The Williams and Wilkins Co, 1991: 432-92.
33. Schwabe C, Anastasi A, Crow H, McDonald JK, Barrett AJ. Cystatin. Amino acid sequence and possible secondary structure. Biochem J 1984 217 : 813 817.
34. Hindler J. Antimicrobial susceptibility testing. In : Isenberg HD (ed Clinical Microbiology Procedures Handbook. Washington, DC: American Society of Microbiology Press, 1992: 5.
35. Bobek LA, Levine MJ. Cystatins-inhibitors of cysteine proteinases. Crit Rev Oral Biol Med 1992 3 : 307 332.
36. Shivaprakasha S, Radhakrishnan K, Karim PM. Candida spp. other than Candida albicans: a major cause of fungaemia in a tertiary care centre. Indian J Med Microbiol 2007 25 : 405 407.
37. Helmerhorst EJ, Hodgson R, van't Hof W, Veerman EC, Allison C, Nieuw Amerongen AV. The effects of histatin-derived basic antimicrobial peptides on oral biofilms. J Dent Res 1999 78 : 1245 1250.
38. Van Nieuw Amerongen A, Bolscher JG, Veerman EC. Salivary proteins: protective and diagnostic value in cariology? Caries Res 2004 38 : 247 253.
39. Goldman MJ, Anderson GM, Stolzenberg ED, Kari UP, Zasloff M, Wilson JM. Human β-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 1997 88 : 553 560.
40. Bals R, Wang X, Wu Z et al. Human β-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J Clin Invest 1998 102 : 874 880.
41. Travis SM, Conway BA, Zabner J et al. Activity of abundant antimicrobials of the human airway. Am J Respir Cell Mol Biol 1999 20 : 872 879.
42. Wang KM, Kumar S, Cheng YS, Venkatagiri S, Yang AH, Yeh KW. Characterization of inhibitory mechanism and antifungal activity between group-1 and group-2 phytocystatins from taro (Colocasia esculenta). FEBS J 2008 275 : 4980 4989.